
南美洲和中美洲医学成像市场预测至 2028 年 - COVID-19 影响和区域分析(按产品)(CT 系统、X 射线系统、PET 系统、MRI 系统、超声系统等);最终用户(医院、手术中心、临床医生办公室和紧急护理中心)
No. of Pages: 144 | Report Code: TIPRE00025114 | Category: Life Sciences
No. of Pages: 144 | Report Code: TIPRE00025114 | Category: Life Sciences
医学成像是指为诊断和治疗目的而创建人体各部位图像的技术和过程。数字健康。术语“医学成像”包括各种放射成像技术,例如:X 射线照相、透视、磁共振成像 (MRI)、医学超声检查或超声波、内窥镜检查、弹性成像、触觉成像、热成像、医学摄影和核医学功能成像技术例如,正电子发射断层扫描(PET)。医学成像在每个医疗环境和各个级别的医疗保健中都至关重要。
因此,对早期诊断的需求不断增加,预计将在未来几年对医学成像产生巨大的需求,并进一步预计这一需求将进一步增加。推动医学影像市场。
巴西和阿根廷等国家也报告了许多冠状病毒感染阳性病例。这些地区的医疗保健和医疗服务业正在发展。这些地区国家高度依赖从发达国家进口的医疗器械。因此,由于供应链的严重中断,各国对医学成像系统的需求面临着多项挑战。卫生当局担心,抗击冠状病毒的尝试将间接导致患者死亡人数增加,包括癌症患者、妇科患者和其他原因的患者。低成本地区的病人死亡人数预计会增加,因为医疗保健专业人员限制病人去尽可能多的诊所检查,诊断中心、门诊手术中心的资源和人员也有限。然而,对计算机断层扫描和超声系统等成像方式的需求不断增加,以管理 COVID-19 患者的治疗。受疫情严重打击的国家每天都会部署大量胸部成像。这些因素促进了该地区医学影像市场的增长。
南美洲和中美洲的医学成像市场预计将从2021年的10.65亿美元增长到2028年的13.168亿美元;预计 2021 年至 2028 年复合年增长率为 3.1%。诊断测试是医疗保健系统不可或缺的一部分,它提供重要信息,使提供者和患者能够做出正确的临床决策。事实上,大约 75% 的临床决策都是基于诊断测试。对更快、更准确的诊断的需求每年以 10% 的速度增长,这增加了成本,并对诊断提供商的能力和能力造成了压力。从患者的角度来看,早期发现和诊断可以防止不必要的痛苦和痛苦。它还可以减少治疗规模和成本。大量研究将早期诊断与可衡量的健康收益联系起来,例如提高生存率和降低治疗成本。此外,政府意识将进一步推动市场增长。
从产品来看,X射线系统细分市场在2020年南美洲和中美洲医疗影像市场中占据最大份额。从最终用户来看,医院细分市场在南美洲和中美洲医疗成像市场中占据最大份额2020 年成像市场。
准备本南美洲和中美洲医学成像市场报告时提到的一些主要一手和二手来源是公司网站、年度报告、财务报告、国家政府文件和统计数据数据库等。报告中列出的主要公司包括通用电气公司、西门子股份公司、荷兰皇家飞利浦公司、岛津制作所、日立有限公司、佳能公司、Hologic, Inc.、Carestream Health Inc.、ESAOTE SPA 和三星集团。
按产品
由最终用户
按国家/地区
Strategic insights for South and Central America Medical Imaging involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 1,065.0 Million |
Market Size by 2028 | US$ 1,316.8 Million |
Global CAGR (2021 - 2028) | 3.1% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 南美洲和中美洲
|
Market leaders and key company profiles |
The regional scope of South and Central America Medical Imaging refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South and Central America Medical Imaging Market is valued at US$ 1,065.0 Million in 2021, it is projected to reach US$ 1,316.8 Million by 2028.
As per our report South and Central America Medical Imaging Market, the market size is valued at US$ 1,065.0 Million in 2021, projecting it to reach US$ 1,316.8 Million by 2028. This translates to a CAGR of approximately 3.1% during the forecast period.
The South and Central America Medical Imaging Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Medical Imaging Market report:
The South and Central America Medical Imaging Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Medical Imaging Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Medical Imaging Market value chain can benefit from the information contained in a comprehensive market report.